High-Throughput Programmable Tumor Spheroid Generation Using the Magneto-Archimedes Effect
Source abstract
Abstract
Three-dimensional (3D) tumor spheroids in vitro have great potential in drug discovery and tissue engineering due to their similarity to real tissues. Herein, we develop a simple strategy, with time and cost-effective, noninvasive characters to produce high-throughput 3D tissue spheroids using the magneto-Archimedes effect. This method is versatile in producing various morphologies of tumor spheroids by using different templates, as well as spatially coded tumor spheroids by adding different cells in the defined orders. The prepared tumor spheroids are similar to the mouse homograft tumors, as confirmed by immunofluorescence experimental results. We demonstrate that the prepared tumor spheroids can be used for anticancer drug screening, tumor inoculations, and the study of chemical signal transduction between artificial cell aggregates and tumor tissues. Temozolomide (TMZ) is found to be more effective than 5-FU toward gliomas. Further, C6 tumor spheroids are successfully inoculated into mice to grow tumors with a rapid growth rate than free cells. In the hybrid structure containing artificial cell aggregates and tumor spheroids, reactive oxygen species (H 2 O 2 ) are generated in the artificial cell aggregates, which diffuse into tumor spheroids to cause the redistribution of intracellular Ca 2+ in tumor cells, consequently inducing cell apoptosis. This method is easy to scale up by using large magnets. It provides great potential in complicated tissue structure construction, antitumor drug screening, and tissue engineering.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Microfluidic and Bio-sensing Technologies · Micro and Nano Robotics · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Urban Water Resource and Environment, School of Chemistry and Chemical Engineering, Harbin Institute of Technology, 92 West Da-Zhi Street, Harbin 150001, China
Funding
China Postdoctoral Science Foundation · Natural Science Foundation of Heilongjiang Province · National Natural Science Foundation of China
References (48)
Show source-provided references
1. 10.1038/nrm85910.1038/nrm859 ↗
2. 10.1002/admt.20200018310.1002/admt.202000183 ↗
3. 10.1016/j.jconrel.2012.04.04510.1016/j.jconrel.2012.04.045 ↗
4. 10.1038/s41578-018-0051-610.1038/s41578-018-0051-6 ↗
5. 10.1038/s41586-020-2099-x10.1038/s41586-020-2099-x ↗
6. 10.1016/j.pharmthera.2016.03.01310.1016/j.pharmthera.2016.03.013 ↗
7. 10.1038/nmat244110.1038/nmat2441 ↗
8. 10.1002/adma.20110196210.1002/adma.201101962 ↗
9. 10.1002/adma.20170315610.1002/adma.201703156 ↗
10. 10.3389/fphar.2018.0000610.3389/fphar.2018.00006 ↗
11. 10.1126/sciadv.aaw511110.1126/sciadv.aaw5111 ↗
12. 10.3390/cells1204064610.3390/cells12040646 ↗
13. 10.1038/s41467-021-21029-210.1038/s41467-021-21029-2 ↗
14. 10.1038/s41598-017-04718-110.1038/s41598-017-04718-1 ↗
15. 10.1038/ncomms525010.1038/ncomms5250 ↗
16. 10.1073/pnas.130948211010.1073/pnas.1309482110 ↗
17. 10.1039/C7MH00677B10.1039/C7MH00677B ↗
18. 10.1039/C9LC00872A10.1039/C9LC00872A ↗
19. 10.1038/nature0776610.1038/nature07766 ↗
20. 10.1038/nature1259110.1038/nature12591 ↗
21. 10.1063/1.358188310.1063/1.3581883 ↗
22. Akiyama, Y.; Morishima, K. In Label-free ultrarapid spheroid formation in microfluidic chip using magneto-archimedes effect; IEEE, 2012; pp. 116–119.10.1109/MEMSYS.2012.6170107 ↗
23. 10.1038/s41467-019-14141-x10.1038/s41467-019-14141-x ↗
24. 10.1038/nrd.2018.610.1038/nrd.2018.6 ↗
25. 10.1002/anie.20200694110.1002/anie.202006941 ↗
26. 10.1073/pnas.150925011210.1073/pnas.1509250112 ↗
27. 10.1039/C8MH01616J10.1039/C8MH01616J ↗
28. 10.1016/j.physb.2004.01.06310.1016/j.physb.2004.01.063 ↗
29. 10.1073/pnas.080186610510.1073/pnas.0801866105 ↗
30. 10.1002/adma.20130453910.1002/adma.201304539 ↗
31. 10.1007/BF0069097410.1007/BF00690974 ↗
32. 10.1371/journal.pone.000279510.1371/journal.pone.0002795 ↗
33. 10.1002/smll.20190129910.1002/smll.201901299 ↗
34. 10.1002/adhm.20190175110.1002/adhm.201901751 ↗
35. 10.1016/j.actbio.2019.06.01210.1016/j.actbio.2019.06.012 ↗
36. 10.1007/s00280-009-1050-510.1007/s00280-009-1050-5 ↗
37. 10.1039/C0AN00609B10.1039/C0AN00609B ↗
38. 10.1002/smll.20190467310.1002/smll.201904673 ↗
39. 10.1002/adfm.20170682710.1002/adfm.201706827 ↗
40. Behrem S. · Croat. Med. J. · 2005 · 46 · 417
41. 10.1002/adfm.20240582310.1002/adfm.202405823 ↗
42. 10.1039/C9SC04522H10.1039/C9SC04522H ↗
43. 10.1002/smll.20190639410.1002/smll.201906394 ↗
44. 10.1016/j.bbamcr.2016.09.01210.1016/j.bbamcr.2016.09.012 ↗
45. 10.1016/j.bbrc.2015.01.13710.1016/j.bbrc.2015.01.137 ↗
46. 10.1016/j.colsurfb.2016.08.01810.1016/j.colsurfb.2016.08.018 ↗
47. 10.1021/jacs.7b0400910.1021/jacs.7b04009 ↗
48. 10.1021/acs.analchem.9b0112810.1021/acs.analchem.9b01128 ↗